axicorp Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 280

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

axicorp General Information

Description

Manufacturer of pharmaceutical medicines based in Friedrichsdorf, Germany. The company offers medicines from European countries for neurology and multiple sclerosis, diabetes, oncology, rheumatology and HIV along with narcotics, thereby enabling patients to get medicines at low costs with the same quality.

Contact Information

Website
www.axicorp.de
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Specialty Retail
Parent Company
Dermapharm
Corporate Office
  • Marie-Curie-Strasse 11
  • 61381 Friedrichsdorf
  • Germany
+49 06172 00000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

axicorp Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore axicorp‘s full profile, request access.

Request a free trial

axicorp Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical medicines based in Friedrichsdorf, Germany. The company offers medicines from European co
Pharmaceuticals
Friedrichsdorf, Germany
280 As of 2023
000000&0

000000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
000000000000000
Bromma, Sweden
0 As of 0000
000.00
000000 - 000 000.00

000000

t nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
000000000000000
Odense, Denmark
0000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

axicorp Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Moberg Pharma Corporation Bromma, Sweden 0 000.00 000000 - 000 000.00
Orifarm Group Corporation Odense, Denmark 0000
You’re viewing 2 of 2 competitors. Get the full list »

axicorp Executive Team (4)

Name Title Board Seat Contact Info
Anna-Karina Drees Managing Director
Achim Berthold Facility, Quality & Drug Safety Officer
Hans-Georg Feldmeier Ph.D Managing Director
You’re viewing 3 of 4 executive team members. Get the full list »

axicorp Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

axicorp Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore axicorp‘s full profile, request access.

Request a free trial

axicorp Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Remedix 25-Jan-2016 0000000000 Distributors (Healthcare)
To view axicorp’s complete acquisitions history, request access »

axicorp Subsidiaries (1)

Company Name Industry Location Founded
Remedix Distributors (Healthcare) Friedrichsdodrf, Germany 0000
To view axicorp’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »